News & Media

Take a closer look at what we’re doing across Teva worldwide

Our latest news

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Sett...

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperi...

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone)

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovat...

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation a

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Confer...

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the T...

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatm

Teva Initiates Voluntary Nationwide Recall of one (1) Lot of Metoclopramide Tablets USP, 10mg

Teva Initiates Voluntary Nationwide Recall of one (1) Lot of Metoclopramide Tablets USP, 10mg

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool ...

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tende

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds...

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to R

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Gr...

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth
See all news items
Previous
Next

Discover the world of Teva

Follow our latest feature stories with news and views from across our global organization

Discover more Discover the world of Teva

Media Resources

Media Inquiries

Contact our corporate communications.

Learn more Media Inquiries

Media Kit

Files and resources for media use only

Download Teva Media Kit Media Kit

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports

Connect with us

Teva Social Media Guidelines.

Learn more Connect with us